Fyodor Biotechnologies, Inc.

Fyodor develops a urine-based malaria diagnostic test that delivers results in minutes without requiring a blood sample. The test has received regulatory approvals in Nigeria, Côte d'Ivoire, Kenya, and the Democratic Republic of Congo, and was validated in collaboration with Johns Hopkins, Duke University, and the University of Lagos.